Journal Watch · Journal of Experimental Medicine · 2026

A circadian checkpoint relocates neutrophils to minimize injury.

Thus, a circadian neutrophil checkpoint protects from exuberant inflammation and can be activated to protect the host.

Aroca-Crevillén A, Martín-Salamanca S, Torres LS et al.Journal of Experimental Medicine3 min readPharma relevance 60/100

DOI: 10.1084/jem.20250240PMID: 41385080Study type: research study

TL;DR

Thus, a circadian neutrophil checkpoint protects from exuberant inflammation and can be activated to protect the host.

Key findings

  • In tissues, this protection was mediated by repositioning neutrophils in the wound core, which spared neighboring host cells from apoptotic death.
  • Thus, a circadian neutrophil checkpoint protects from exuberant inflammation and can be activated to protect the host.

What they did

Here, we show that the periods of diurnal protection coincide with peaks in plasma CXCL12, a chemokine that inhibits the neutrophil-intrinsic circadian clock by signaling through CXCR4. Genetic deletion of this clock, or a hyperactive form of CXCR4, prevented the diurnal spikes of injury, and treatment with a synthetic CXCR4 agonist conferred protection from myocardial and vascular injury.

Full abstract (original)

Background: Inflammation-driven injury, a significant source of morbidity and mortality worldwide, is largely mediated by the cytotoxic activities of neutrophils, which extend the initial lesion and jeopardize organ function. Intriguingly, inflammatory injury naturally declines at specific times of day, suggesting that circadian mechanisms exist that mitigate the destructive activity of neutrophils and protect the host.

What they did: Here, we show that the periods of diurnal protection coincide with peaks in plasma CXCL12, a chemokine that inhibits the neutrophil-intrinsic circadian clock by signaling through CXCR4. Genetic deletion of this clock, or a hyperactive form of CXCR4, prevented the diurnal spikes of injury, and treatment with a synthetic CXCR4 agonist conferred protection from myocardial and vascular injury.

Results & conclusions: In tissues, this protection was mediated by repositioning neutrophils in the wound core, which spared neighboring host cells from apoptotic death. Thus, a circadian neutrophil checkpoint protects from exuberant inflammation and can be activated to protect the host.

Abstract © the authors / Journal of Experimental Medicine (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1084/jem.20250240 · PubMed 41385080.

Why it matters for pharma & biotech

  • Directly relevant to teams in targeted oncology / immuno-oncology, small-molecule drug discovery — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Modalities & themes detected: targeted oncology / immuno-oncology · small-molecule drug discovery

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Journal of Experimental Medicine study find?

Thus, a circadian neutrophil checkpoint protects from exuberant inflammation and can be activated to protect the host.

What type of study is this?

It is a research study, published in Journal of Experimental Medicine in 2026. Here, we show that the periods of diurnal protection coincide with peaks in plasma CXCL12, a chemokine that inhibits the neutrophil-intrinsic circadian clock by signaling through CXCR4.

Where can I read the original paper?

The original is at the publisher via DOI 10.1084/jem.20250240. PubMed ID: 41385080. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Aroca-Crevillén A, Martín-Salamanca S, Torres LS et al.. A circadian checkpoint relocates neutrophils to minimize injury.. Journal of Experimental Medicine (2026). DOI: 10.1084/jem.20250240.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/a-circadian-checkpoint-relocates-neutrophils-to-minimize-injury-250240/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides